EXTRAPYRAMIDAL REACTION ASSOCIATED WITH ONDANSETRON

被引：16

作者：

GARCIADELMURO, X

CARDENAL, F

FERRER, P

机构：

[1] CIUTAT SANITARIA BELLVITGE,DEPT MED ONCOL,BARCELONA,SPAIN

[2] CIUTAT SANITARIA BELLVITGE,DEPT CLIN PHARMACOL,BARCELONA,SPAIN

来源：

EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 02期

关键词：

D O I：

10.1016/0959-8049(93)90199-P

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：288 / 288

页数：1

共 6 条

[1] EXTRAPYRAMIDAL REACTION CAUSED BY ONDANSERTRON [J].

DOBROW, RB ;

COPPOCK, MA ;

HOSENPUD, JR .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) :1921-1921

[2]

HALPERIN JR, 1992, CANCER, V69, P1275

[3]

KANAREK BB, 1992, J CLIN ONCOL, V10, P507

[4] COMPARISON OF THE 5-HYDROXYTRYPTAMINE3 (SEROTONIN) ANTAGONIST ONDANSETRON (GR-38032F) WITH HIGH-DOSE METOCLOPRAMIDE IN THE CONTROL OF CISPLATIN-INDUCED EMESIS [J].

MARTY, M ;

POUILLART, P ;

SCHOLL, S ;

DROZ, JP ;

AZAB, M ;

BRION, N ;

PUJADELAURAINE, E ;

PAULE, B ;

PAES, D ;

BONS, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) :816-821

[5] AGE AND GENDER EFFECTS ON ONDANSETRON PHARMACOKINETICS - EVALUATION OF HEALTHY AGED VOLUNTEERS [J].

PRITCHARD, JF ;

BRYSON, JC ;

KERNODLE, AE ;

BENEDETTI, TL ;

POWELL, JR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :51-55

[6]

SMITH RN, 1989, EUR J CANC CLIN O S1, V25, P47

← 1 →